Reven Pharmaceuticals wins FDA nod of IND application for COVID treatment with Rejuveinix
GOLDEN -- Reven today announced the U.S. Food and Drug Administration has approved its Investigational New Drug application in connection with its lead anti-inflammatory/anti-oxidant... Read More
Thursday October 22, 2020 0 comments
NREL, UK university partner to dive deeper into how enzymes digest plastic
GOLDEN -- A... Read More
Friday October 2, 2020 0 comments
Reven selects eClinical services provider DSG to accelerate Reven’s RJX as treatment for COVID-19
GOLDEN -- Reven Holdings, Inc. today announced it selected DSG, Inc., a leading global eClinical services provider, for all aspects of clinical trial data management during its upcoming COVID-19... Read More
Wednesday September 30, 2020 0 comments
Reven’s patented treatment platform for sepsis on track for testing COVID-19 patients
GOLDEN -- Reven Holdings, a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery and development of novel treatment platforms for cancer, viral... Read More
Tuesday September 15, 2020 0 comments
Silver Bullet Water Treatment appoints Will Sarni to board of directors
GOLDEN -- Water industry veteran Will Sarni has been appointed to serve on the board of directors for Silver Bullet Water Treatment. Sarni is an internationally recognized thought leader on... Read More
Monday August 31, 2020 0 comments
NREL names Daniel Beckley to lead facilities and operations
GOLDEN -- The U.S. Department of Energy’s National Renewable Energy Laboratory (NREL) recently made a key hire to a laboratory leadership position, naming Daniel Beckley as associate laboratory... Read More
Thursday July 16, 2020 0 comments
Meritech collaborates with Eagle Protect to provide gloving resource center
GOLDEN -- Meritech announced it is taking proactive steps to protect the health and safety of the general public by providing a Gloving Resource Center with content created in partnership with... Read More
Wednesday July 1, 2020 0 comments
PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology
GOLDEN -- PharmaJet announced that its Needle-free Injection System technology will be used to deliver a messenger RNA (mRNA) vaccine against SARS-CoV-2. The vaccine is being developed by Abnova... Read More
Wednesday May 20, 2020 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
